Healthtech Growth Investors & VC Firms
1270 firms in this list, with a median first check of $1.6M. 311 of them lead rounds. Generated from verified public data and updated continuously.
PruVen Capital Partners
Los AltosSeed–Growth$100K – $10M
7 people
Amicus Capital Partners
BangaloreGrowth
21 people
HealthQuest Capital
Redwood CityGrowth–Late Stage
14 people
Sawari Ventures
CairoSeed–Growth$200K – $2M
17 people
Crescent Capital Partners
SydneyGrowth–Late Stage$13.2M – $52.8M
24 people
Bregal Sagemount
New YorkGrowth
14 people
Cottonwood Technology Fund
DenverPre-Seed–Growth$1M – $25M
11 people
Elysian Park Ventures
Los AngelesPre-Seed–Late Stage$500K – $100M
14 people
Mubadala Capital
Abu DhabiSeries A–Late Stage$1M – $50M
8 people
SQN Venture Partners, LLC
CharlestonSeed–Growth
11 people
Unison Capital
TokyoGrowth
8 people
QuestMark Partners
BaltimoreGrowth$5M – $15M
7 people
Catalyst Romania
BucharestSeed–Growth$1.1M – $3.3M
14 people
Jacobs Holding AG
ZurichGrowth–Late Stage$100M – $300M
23 people
Next Billion Capital Partners
Growth
14 people
Perennial Partners
SydneyGrowth–Late Stage
1 person
Ascendo Ventures
SeoulPre-Seed–Growth
10 people
Planven Entrepreneur Ventures
ZurichGrowth$10M – $20M
19 people
Starquest Capital
ParisSeed–Growth$550K – $22M
13 people
Elysian
LondonGrowth–Late Stage
18 people
Movens Capital
WarsawPre-Seed–Growth$250K – $3M
12 people
Prysm Capital
San FranciscoGrowth
18 people
Venture Ontario
TorontoSeed–Growth
3 people
AF WPartners
SeoulSeed–Growth
11 people
Related lists
Growth Investors & VC Firms (4264)Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)Growth Investors & VC Firms in North America (2122)Growth Investors & VC Firms in United States (1838)Growth Investors & VC Firms in Europe (1634)Healthtech Pre-Seed Investors & VC Firms (1468)
Data sourced from public filings and firms' own websites — see our methodology.




































































































